Case Report
Copyright ©The Author(s) 2022.
World J Clin Cases. Jun 26, 2022; 10(18): 6141-6147
Published online Jun 26, 2022. doi: 10.12998/wjcc.v10.i18.6141
Table 1 Patients’ information statistics for subcutaneous infection caused by nontuberculous mycobacteria following cosmetic procedures
No
Ref.
Sex/Age (yr)
Duration after injection (mo/wk/d)
Skin symptoms
Site of infection
Culture
Treatment and course
Outcome
P1The present caseF/53Botulinum toxin (1.5 mo)ErythematousnodulesCheek, foreheadM. abscessusClarithromycin, moxifloxacin, amikacin 2/d (7 mo)Cure
P2Chen et al[2]F/32Botulinum toxin (2 mo)Nodules and abscessesForehead and periorbial areasM. abscessusClarithromycin 250 mg 2/d, rifampicin 450 mg 1/d, and ethambutol 250 mg 3/d (3 mo)Cure
P3Chen et al[2]F/34Botulinum toxin (10 d)Painful papules and nodulesLower jaw, malar, and temple regionsM. abscessusClarithromycin 250 mg 2/d, rifampicin 450 mg 1/d (6 mo)Cure
P4Mello et al[3]F/28Sunflower oil, deoxycholate, sinetrol, and caffeine subcutaneous application (4 wk)Pain and erythema Abdomen and flanksM. lentiflavumClarithromycin, 500 mg 2/d and levofloxacin 500 mg 1/d (8 mo)Cure
P5Tan et al[4]F/36.6 (28-45) (5 cases)Autologous fat grafting for cosmetic breast augmentation (20 d)Erythema, breast contour disruption, breast asymmetryBreastM. Fortuitum (2), M. abscessus (1), and M. chelonei (2)Clarithromycin 500 mg 2/d, amikacin 800 mg 1/d, and imipenem 500 mg 4/d (54 wk) Azithromycin 500 mg 1/d, ethambutol 750 mg 1/d, rifampicin 600 mg 1/d (6 mo), and surgical debridementCure
P6Yeon et al[6]F/34Botulinum toxin (3.5 mo)ErythematousnodulesLeft mandibleM. immunogemomClarithromycin 500 mg 2/d (7 m)Cure
P7Fang et al[7]F/28Botulinum toxin (2 wk)Erythemaand painful nodulesLower extremitiesM. abscessusClarithromycin, moxifloxacin, and rifampicin (6 mo)Cure
P8Thanas arnaksorn et al[8]F/42Botulinum toxin (5 wk)Erythematous nodulesFrontalis area and right orbicularis oculi areaHistopathologically confirmedClarithromycin 500 mg/d and levofloxacin500 mg/d (6 mo)Cure
P9Saeb-Lima et al[9]F/45Botulinum toxin (5 mo)Erythematousplaques and nodulesProcerus muscle zone and the pars externa of orbicularis oculi muscleHistopathologically confirmedClarithromycin, azithromycin, and rifampicin (40 d)Cure
P10Hammond et al[10]F/40Lipofilling (2 mo)Multiple painful nodulesButtockM. chelonaeClarithromycin 500 mg 2/d (2.5 mo), ciprofloxacin 500mg 2/d (3 mo), and surgeryCure
P11Yoo et al[11]F/56Filler injections (3 mo)NodulesCheek M. volinskyiDoxycycline 100 mg 2/d and ciprofloxacin 750 mg 6/d (5 mo)Cure
P12Fiore et al[12]F/31Poly-L-lactic acid (3 mo)Erythematous nodulesCheekM. mucogenicumCiprofloxacin 500 mg and clarithromycin 500 mg 2/d (6 mo)Cure
P13Eustace et al[13]M/28Hair transplant (2 mo) NodulesSculpM. abscessusClarithromycin 250 mg 2/d, doxycycline 100 mg 1/d (3 mo), and drainageCure
P14Yang et al[14]F/29Facial injection with autologous fat (9 mo)AbscessesTemporal and lower orbital regionsM. abscessusMoxifloxacin, clarithromycin, and ethambutol (12 mo)Cure